These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 23681221

  • 1. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP, Chapman FA, Bellamy CO, Save V, Plevris JN, Shand AG, Whitworth C, Dhaun N.
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.
    Iizuka M, Konno S, Horie Y, Itou H, Shindo K, Watanabe S.
    Gut; 2006 May; 55(5):744-5. PubMed ID: 16609139
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y, Debbeche R, Hamzaoui L, Lounissi M, Trabelsi S, Bouzaidi S, Salem M, Abdelmoula L, Najjar T.
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract] [Full Text] [Related]

  • 12. [An unexplained inflammatory syndrome could be due to renal amyloidosis associated to Crohn's disease].
    Fekih M, Hefaiedh R, Matri S, Djebbi S, Boubaker J, Filali A.
    Tunis Med; 2008 Nov; 86(11):1022-3. PubMed ID: 19213504
    [No Abstract] [Full Text] [Related]

  • 13. Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease.
    Fernández-Nebro A, Ureña I, Irigoyen MV, García-Vicuña R.
    Gut; 2006 Nov; 55(11):1666-7; author reply 1667. PubMed ID: 17047117
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?
    Sorrentino D, Nash P, Viladomiu M, Hontecillas R, Bassaganya-Riera J.
    Inflamm Bowel Dis; 2014 Apr; 20(4):757-66. PubMed ID: 24572206
    [No Abstract] [Full Text] [Related]

  • 16. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E, Pugh S, Fox R.
    J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
    [No Abstract] [Full Text] [Related]

  • 17. Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease--what is the role of anti-TNF antibody?
    Farkas K, Nagy F, Kovács L, Wittmann T, Molnár T.
    J Crohns Colitis; 2013 May; 7(4):e143-5. PubMed ID: 22818164
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins.
    Bach H, Rosenfeld G, Bressler B.
    J Crohns Colitis; 2012 Jun; 6(5):628-9. PubMed ID: 22398081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.